Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Btk inhibitors in atherosclerosis
Jonathan R. Lindner
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Btk inhibitors in atherosclerosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Agammaglobulinaemia Tyrosine Kinase
100%
Atherosclerotic Plaques
71%
Platelet Aggregation
68%
Atherosclerosis
55%
Chemical Compounds
Tyrosine Kinase Inhibitor
95%